Scott Letendre spends much of his time researching Immunology, Neurocognitive, Viral load, Internal medicine and Cerebrospinal fluid. His Immunology research includes elements of Acquired immunodeficiency syndrome, Central nervous system and Virology. Scott Letendre interconnects HIV-associated neurocognitive disorder, Dementia and Neuropsychology in the investigation of issues within Neurocognitive.
His Viral load study integrates concerns from other disciplines, such as Regimen, White matter, Progressive multifocal leukoencephalopathy and Lentivirus. His research integrates issues of Physical therapy, Oncology and Ritonavir in his study of Internal medicine. His study in Cerebrospinal fluid is interdisciplinary in nature, drawing from both Interquartile range, Reverse transcriptase, Chemokine, Blood plasma and Prospective cohort study.
The scientist’s investigation covers issues in Neurocognitive, Immunology, Internal medicine, Cerebrospinal fluid and Viral load. His Neurocognitive study incorporates themes from Clinical psychology, Acquired immunodeficiency syndrome and Neuropsychology. His work carried out in the field of Immunology brings together such families of science as Central nervous system, HIV-associated neurocognitive disorder and Virology.
His Internal medicine research includes themes of Endocrinology, Depression and Oncology. The study incorporates disciplines such as Chemokine, Blood plasma, Antiretroviral therapy, Biomarker and Pharmacology in addition to Cerebrospinal fluid. His research is interdisciplinary, bridging the disciplines of Regimen and Viral load.
Scott Letendre mostly deals with Neurocognitive, Internal medicine, Cerebrospinal fluid, Immunology and Cohort. Neurocognitive is the subject of his research, which falls under Psychiatry. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Viral load, Oncology and Depression.
His research investigates the connection between Cerebrospinal fluid and topics such as Pharmacology that intersect with issues in Brain function. His Immunology research is multidisciplinary, incorporating elements of Disease, Neurodegeneration and Antiretroviral therapy. The Cohort study which covers Odds ratio that intersects with Confidence interval and Body mass index.
His primary scientific interests are in Neurocognitive, Cerebrospinal fluid, Internal medicine, Antiretroviral therapy and Immunology. The various areas that he examines in his Neurocognitive study include Confounding, Gerontology, Cannabis and Comorbidity. His biological study spans a wide range of topics, including Quality of life and Acquired immunodeficiency syndrome.
His Cerebrospinal fluid research integrates issues from RNA, Regimen, Viral load, Pharmacology and Cohort. His research in Viral load focuses on subjects like Interleukin 8, which are connected to Neuropsychology and Disease. His studies in Internal medicine integrate themes in fields like Gastroenterology and Neurologic Findings.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
Robert K. Heaton;Donald R. Franklin;Ronald J. Ellis;J. Allen McCutchan.
Journal of NeuroVirology (2011)
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
Scott Letendre;Jennifer Marquie-Beck;Edmund Capparelli;Brookie Best.
JAMA Neurology (2008)
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.
Ronald J. Ellis;Jayraan Badiee;Florin Vaida;Scott Letendre.
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Christina M. Marra;Yu Zhao;David B. Clifford;Scott Letendre.
Correction: Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART
Michelli Faria de Oliveira;Ben Murrell;Josué Pérez-Santiago;Milenka Vargas.
Scientific Reports (2016)
Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral Therapy
Tricia H. Burdo;Margaret R. Lentz;Patrick Autissier;Anitha Krishnan.
The Journal of Infectious Diseases (2011)
Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Robert K. Heaton;Donald R. Franklin;Reena Deutsch;Scott Letendre.
Clinical Infectious Diseases (2015)
Co-Morbidities in Persons Infected with HIV: Increased Burden with Older Age and Negative Effects on Health-Related Quality of Life
Alan T Rodriguez-Penney;Jennifer E Iudicello;Patricia K Riggs;Katie Doyle.
Aids Patient Care and Stds (2013)
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.
Igor Grant;Donald R. Franklin;Reena Deutsch;Steven P. Woods.
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
Scott L Letendre;J Allen McCutchan;Meredith E Childers;Steven P Woods.
Annals of Neurology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: